HU9401948D0 - Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists - Google Patents

Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists

Info

Publication number
HU9401948D0
HU9401948D0 HU9401948A HU9401948A HU9401948D0 HU 9401948 D0 HU9401948 D0 HU 9401948D0 HU 9401948 A HU9401948 A HU 9401948A HU 9401948 A HU9401948 A HU 9401948A HU 9401948 D0 HU9401948 D0 HU 9401948D0
Authority
HU
Hungary
Prior art keywords
hydrogen
alkyl
phenyl
preparation
receptor antagonists
Prior art date
Application number
HU9401948A
Other languages
English (en)
Other versions
HUT70395A (en
Inventor
Mario Varasi
Franco Heidempergher
Carla Caccia
Claudio Arrigoni
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of HU9401948D0 publication Critical patent/HU9401948D0/hu
Publication of HUT70395A publication Critical patent/HUT70395A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU9401948A 1992-11-18 1993-10-22 Phenyl-imidazolidinone derivatives, pharmaceutical compns. contg. them and process for the preparation, ot the said compds. use as 5ht3 receptor antagonists HUT70395A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929224144A GB9224144D0 (en) 1992-11-18 1992-11-18 Phenyl-imidazolidinone derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
HU9401948D0 true HU9401948D0 (en) 1994-09-28
HUT70395A HUT70395A (en) 1995-10-30

Family

ID=10725269

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401948A HUT70395A (en) 1992-11-18 1993-10-22 Phenyl-imidazolidinone derivatives, pharmaceutical compns. contg. them and process for the preparation, ot the said compds. use as 5ht3 receptor antagonists

Country Status (19)

Country Link
US (1) US5424328A (hu)
EP (1) EP0623114B1 (hu)
JP (1) JP3794696B2 (hu)
CN (1) CN1093702A (hu)
AT (1) ATE179701T1 (hu)
AU (1) AU666793B2 (hu)
CA (1) CA2127536C (hu)
DE (1) DE69324794T2 (hu)
ES (1) ES2133415T3 (hu)
FI (1) FI943376A0 (hu)
GB (1) GB9224144D0 (hu)
HU (1) HUT70395A (hu)
IL (1) IL107371A (hu)
NZ (1) NZ257117A (hu)
PL (1) PL174416B1 (hu)
RU (1) RU2126403C1 (hu)
TW (1) TW233297B (hu)
WO (1) WO1994011347A1 (hu)
ZA (1) ZA938206B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780492A (en) * 1996-04-03 1998-07-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6455424B1 (en) * 2000-08-07 2002-09-24 Micron Technology, Inc. Selective cap layers over recessed polysilicon plugs
EP2858501A4 (en) * 2012-05-22 2015-12-09 Merck Sharp & Dohme TRK-A KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459757A (en) * 1965-10-22 1969-08-05 American Cyanamid Co Imidazolidines
US3491098A (en) * 1967-05-29 1970-01-20 Sterling Drug Inc 1-((imidazolyl)-lower-alkyl)-4-substituted-piperazines
US3702327A (en) * 1970-12-28 1972-11-07 Aldrich Chem Co Inc N-beta-1-(3-phenylimidazolidin-2-one)ethyl 4,4-ethylene dioxypiperidines
JPS6133172A (ja) * 1984-07-24 1986-02-17 Kotobuki Seiyaku Kk １，３−置換−２−イミダゾリジノン誘導体，胃腸運動亢進剤及びその製造方法
US4600430A (en) * 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
FI90869C (fi) * 1986-11-14 1994-04-11 Tanabe Seiyaku Co Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi
IE63474B1 (en) * 1987-12-24 1995-04-19 Wyeth John & Brother Ltd Heterocyclic compounds
IT1230703B (it) * 1989-01-26 1991-10-29 Luso Farmaco Inst Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
GB2248058B (en) * 1990-09-21 1994-09-14 Orion Yhtymae Oy Aromatase inhibiting 4(5)-imidazoles
GB9106571D0 (en) * 1991-03-27 1991-05-15 Erba Carlo Spa Derivatives of substituted imidazol-2-one and process for their preparation
GB9020889D0 (en) * 1990-09-25 1990-11-07 May & Baker Ltd New compositions of matter
IT1255802B (it) * 1992-08-07 1995-11-16 Luso Farmaco Inst Derivati imidazolici ad attivita' a ii antagonista

Also Published As

Publication number Publication date
IL107371A (en) 1998-02-08
RU2126403C1 (ru) 1999-02-20
RU94036775A (ru) 1996-05-27
JPH07503256A (ja) 1995-04-06
EP0623114B1 (en) 1999-05-06
US5424328A (en) 1995-06-13
ES2133415T3 (es) 1999-09-16
IL107371A0 (en) 1994-01-25
TW233297B (hu) 1994-11-01
FI943376A (fi) 1994-07-15
NZ257117A (en) 1995-08-28
PL304676A1 (en) 1995-01-09
DE69324794T2 (de) 1999-12-02
ZA938206B (en) 1994-06-10
FI943376A0 (fi) 1994-07-15
DE69324794D1 (de) 1999-06-10
AU5336494A (en) 1994-06-08
HUT70395A (en) 1995-10-30
CA2127536C (en) 2005-09-06
EP0623114A1 (en) 1994-11-09
CA2127536A1 (en) 1994-05-26
CN1093702A (zh) 1994-10-19
PL174416B1 (pl) 1998-07-31
WO1994011347A1 (en) 1994-05-26
ATE179701T1 (de) 1999-05-15
GB9224144D0 (en) 1993-01-06
JP3794696B2 (ja) 2006-07-05
AU666793B2 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
EG20280A (en) Process for preparing of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
GR3026231T3 (en) 3-aminopiperidine derivatives and related nitrogen containing heterocycles.
IL103657A0 (en) Acyclic ethylenediamine derivatives
NZ515408A (en) 5-phenyl-pyrimidine derivatives
SI0773943T1 (en) Compounds useful as antiproliferative agents and garft inhibitors
HUT68056A (en) Substituted indoles and azaindoles as angiotensin ii antagonists, pharmaceutical compositions containing same, process for their production and intermediates
GB9806692D0 (en) Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB9306886D0 (en) Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
HU9401948D0 (en) Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists
JO2261B1 (en) Derivatives 4 - Phenylbarmidine
HUT59678A (en) Process for producing dihydrobenzofurane-carboxamide derivatives
IL110894A0 (en) Cephem derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
FI921308A (fi) Foerfarande foer framstaellning av derivat av substituerad imidazol-2-on
ZA941964B (en) Substituted (arylalkylaminobezyl) aminopropionamide derivatives and process for their preparation
AP9801410A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists.
AU5674894A (en) Azanoradamantanes
GR3036825T3 (en) 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety
AU7458894A (en) 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
ES2056025A1 (es) Nuevos derivados de indol.

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal